Weiwei Lu
Impact in
-
- COVID-19 Clinical Research Studies
- Parasitic Diseases Research and Treatment
Papers in
-
- Osteoarthritis Treatment and Mechanisms 3
-
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Yongfen Qi (17 shared papers)Yan-Rong Yu (11 shared papers)Chaoshu Tang (9 shared papers)Xian-Qiang Ni (8 shared papers)Changcheng Zhou (5 shared papers)Jin‐Sheng Zhang (6 shared papers)Zheng‐tao Lv (3 shared papers)Anmin Chen (3 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)The International Journal of Advanced Manufacturing Technology (2 papers)Peptides (2 papers)Atherosclerosis (2 papers)Annals of Palliative Medicine (2 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Weiwei Lu
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Infectious Diseases 133
- Aging 13
- Rheumatology 90
- Parasitology 40
- Biochemistry 42
Countries citing papers authored by Weiwei Lu
This map shows the geographic impact of Weiwei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Lu more than expected).
Fields of papers citing papers by Weiwei Lu
This network shows the impact of papers produced by Weiwei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Lu. The network helps show where Weiwei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 122 | |
| 2 | 2016 | 58 | |
| 3 | 2018 | 56 | |
| 4 | 2017 | 51 | |
| 5 | 2016 | 49 | |
| 6 | 2023 | 49 | |
| 7 | 2014 | 48 | |
| 8 | 2014 | 47 | |
| 9 | 2013 | 47 | |
| 10 | 2018 | 43 | |
| 11 | 2016 | 42 | |
| 12 | 2014 | 35 | |
| 13 | 2021 | 31 | |
| 14 | 2016 | 29 | |
| 15 | 2016 | 28 | |
| 16 | 2020 | 27 | |
| 17 | 2018 | 27 | |
| 18 | 2020 | 26 | |
| 19 | 2015 | 26 | |
| 20 | 2017 | 23 |
About Weiwei Lu
Weiwei Lu is a scholar working on Rheumatology, Pharmacology, Immunology, Surgery and Infectious Diseases, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Aortic aneurysm repair treatments (3 papers), Hormonal Regulation and Hypertension (3 papers), Fibroblast Growth Factor Research (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers), Chemokine receptors and signaling (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Infectious Diseases (133 citations), Aging (13 citations), Rheumatology (90 citations), Parasitology (40 citations) and Biochemistry (42 citations). Weiwei Lu has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Yongfen Qi, Yan-Rong Yu, Chaoshu Tang, Xian-Qiang Ni, Changcheng Zhou, Jin‐Sheng Zhang, Zheng‐tao Lv, Anmin Chen, Jinsheng Zhang and Zhaojie Meng. Their work appears in journals such as Frontiers in Pharmacology, The International Journal of Advanced Manufacturing Technology, Peptides, Atherosclerosis and Annals of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.